Literature DB >> 21383062

Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.

Amit Kumar1, Javier Redondo-Muñoz, Vicente Perez-García, Isabel Cortes, Monica Chagoyen, Ana C Carrera.   

Abstract

Class I(A) phosphoinositide 3-kinases (PI3Ks) are heterodimeric enzymes composed of a p85 regulatory and a p110 catalytic subunit that induce the formation of 3-polyphosphoinositides, which mediate cell survival, division, and migration. There are two ubiquitous PI3K isoforms p110α and p110β that have nonredundant functions in embryonic development and cell division. However, whereas p110α concentrates in the cytoplasm, p110β localizes to the nucleus and modulates nuclear processes such as DNA replication and repair. At present, the structural features that determine p110β nuclear localization remain unknown. We describe here that association with the p85β regulatory subunit controls p110β nuclear localization. We identified a nuclear localization signal (NLS) in p110β C2 domain that mediates its nuclear entry, as well as a nuclear export sequence (NES) in p85β. Deletion of p110β induced apoptosis, and complementation with the cytoplasmic C2-NLS p110β mutant was unable to restore cell survival. These studies show that p110β NLS and p85β NES regulate p85β/p110β nuclear localization, supporting the idea that nuclear, but not cytoplasmic, p110β controls cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383062      PMCID: PMC3133359          DOI: 10.1128/MCB.01313-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

Review 1.  Regulation of nuclear localization: a key to a door.

Authors:  A Kaffman; E K O'Shea
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis.

Authors:  C Y Hsu; B Y Yung
Journal:  Int J Cancer       Date:  2000-11-01       Impact factor: 7.396

3.  Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N.

Authors:  K Ye; K J Hurt; F Y Wu; M Fang; H R Luo; J J Hong; S Blackshaw; C D Ferris; S H Snyder
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

4.  Oncogenic signaling of class I PI3K isoforms.

Authors:  A Denley; S Kang; U Karst; P K Vogt
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

5.  Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.

Authors:  Miriam Marqués; Amit Kumar; Isabel Cortés; Ana Gonzalez-García; Carmen Hernández; M Carmen Moreno-Ortiz; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

6.  The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.

Authors:  Chuan-Hsiang Huang; Diana Mandelker; Oleg Schmidt-Kittler; Yardena Samuels; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Sandra B Gabelli; L Mario Amzel
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

7.  Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.

Authors:  Shidong Jia; Zhenning Liu; Sen Zhang; Pixu Liu; Lei Zhang; Sang Hyun Lee; Jing Zhang; Sabina Signoretti; Massimo Loda; Thomas M Roberts; Jean J Zhao
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

Review 8.  Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.

Authors:  A M Martelli; L Cocco; S Capitani; S Miscia; S Papa; F A Manzoli
Journal:  Eur J Histochem       Date:  2007       Impact factor: 3.188

9.  I-TASSER server for protein 3D structure prediction.

Authors:  Yang Zhang
Journal:  BMC Bioinformatics       Date:  2008-01-23       Impact factor: 3.169

10.  Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.

Authors:  Nabil Miled; Ying Yan; Wai-Ching Hon; Olga Perisic; Marketa Zvelebil; Yuval Inbar; Dina Schneidman-Duhovny; Haim J Wolfson; Jonathan M Backer; Roger L Williams
Journal:  Science       Date:  2007-07-13       Impact factor: 47.728

View more
  34 in total

1.  Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.

Authors:  Vicente Pérez-García; Javier Redondo-Muñoz; Amit Kumar; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

Review 2.  PI3Kβ-A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling.

Authors:  Anne R Bresnick; Jonathan M Backer
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

3.  CXCL12-mediated murine neural progenitor cell movement requires PI3Kβ activation.

Authors:  Borja L Holgado; Laura Martínez-Muñoz; Juan Antonio Sánchez-Alcañiz; Pilar Lucas; Vicente Pérez-García; Gema Pérez; José Miguel Rodríguez-Frade; Marta Nieto; Oscar Marín; Yolanda R Carrasco; Ana C Carrera; Manuel Alvarez-Dolado; Mario Mellado
Journal:  Mol Neurobiol       Date:  2013-04-19       Impact factor: 5.590

Review 4.  Classes of phosphoinositide 3-kinases at a glance.

Authors:  Steve Jean; Amy A Kiger
Journal:  J Cell Sci       Date:  2014-03-01       Impact factor: 5.285

5.  Phosphoinositide 3-kinase beta protects nuclear envelope integrity by controlling RCC1 localization and Ran activity.

Authors:  Javier Redondo-Muñoz; Vicente Pérez-García; María J Rodríguez; José M Valpuesta; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2014-10-27       Impact factor: 4.272

6.  Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K).

Authors:  Yoshihiro Ito; Jonathan R Hart; Lynn Ueno; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 7.  PI-3 kinase p110β: a therapeutic target in advanced prostate cancers.

Authors:  Benyi Li; Aijing Sun; Wencong Jiang; J Brantley Thrasher; Paul Terranova
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

8.  CRKL Mediates p110β-Dependent PI3K Signaling in PTEN-Deficient Cancer Cells.

Authors:  Jing Zhang; Xueliang Gao; Fabienne Schmit; Guillaume Adelmant; Michael J Eck; Jarrod A Marto; Jean J Zhao; Thomas M Roberts
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

9.  The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.

Authors:  Brittany Aguila; Adina Brett Morris; Raffaella Spina; Eli Bar; Julie Schraner; Robert Vinkler; Jason W Sohn; Scott M Welford
Journal:  Cancer Lett       Date:  2019-08-01       Impact factor: 8.679

10.  Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms.

Authors:  Stanley Andrisse; Shameka Childress; Yaping Ma; Katelyn Billings; Yi Chen; Ping Xue; Ashley Stewart; Momodou L Sonko; Andrew Wolfe; Sheng Wu
Journal:  Endocrinology       Date:  2017-03-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.